Total planned funding: $230,613,751
Allocations
Countries/Regions
Eswatini | $230,613,751 |
Organizational Types
Private Contractor | $65,082,350 |
University | $42,035,317 |
NGO | $40,601,184 |
Unknown | $30,149,908 |
Own Agency | $29,330,035 |
FBO | $8,611,975 |
Host Country Government Agency | $7,706,039 |
Multi-lateral Agency | $6,379,130 |
Other USG Agency | $717,813 |
Program Areas
Care | $80,994,006 |
Treatment | $49,296,319 |
Prevention | $39,936,857 |
Governance and Systems | $23,094,566 |
Testing | $21,816,445 |
Management and Operations | $15,475,558 |
Budget Codes
HBHC: Care: Adult Care and Support | $38,640,114 |
HTXS: Treatment: Adult Treatment | $36,803,984 |
HKID: Care: Orphans and Vulnerable Children | $24,097,529 |
HVCT: Testing: HIV Testing and Counseling | $21,816,445 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $15,580,814 |
HVMS: Management and Operations | $15,475,558 |
HVOP: Sexual Prevention: Other Sexual Prevention | $12,600,291 |
HVTB: Care: TB/HIV | $11,321,436 |
OHSS: Health Systems Strengthening | $11,000,269 |
HTXD: Treatment: ARV Drugs | $8,965,097 |
HVSI: Strategic Information | $8,618,692 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $7,369,696 |
PDCS: Care: Pediatric Care and Support | $6,934,927 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $3,559,085 |
PDTX: Treatment: Pediatric Treatment | $3,527,238 |
HLAB: Laboratory Infrastructure | $3,475,605 |
HMBL: Biomedical Prevention: Blood Safety | $826,971 |
HMIN: Biomedical Prevention: Injection Safety | $0 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $0 |
Top Partner Programs
Columbia University:
$34,972,782
Countries/Regions
Pact, Inc.:
$26,904,051
Countries/Regions
Not Available:
$25,750,922
Countries/Regions
USG Aggregated Agencies:
$16,119,283
Countries/Regions